Nicholas Guionneau - Profile and Investment Details

Investor Profile

Nicholas Guionneau is a Venture Capital, Private Equity Firm, Investment Partner, Investor based in United Kingdom with a diverse investment portfolio that includes companies such as ProSomnus® Sleep Technologies, Amalgam Rx, Roshal Health, Orasis Pharmaceuticals, Proto Axiom, LifeSprout, Inc., Leo Cancer Care, Blackrock Neurotech, Character Biosciences Related to search terms in your querySetPoint Medical, Syndeio Related to search terms in your query Biosciences Related to search terms in your query, . Over time, Nicholas Guionneau has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Nicholas Guionneau is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Equities, Investment Management, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Startups, Finance, Intellectual Property, Biotechnology, Medical Devices, Drug Development, Market Research, Entrepreneurship, Innovation, Clinical Trials, Disruptive technology, Technology Transfer, Market Intelligence, B2B, Therapeutics, Health Tech, Data Solutions may find it worthwhile to explore potential connections with Nicholas Guionneau, as their portfolio suggests a familiarity and interest in this area.

Understanding Nicholas Guionneau’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.